585 filings
Page 5 of 30
8-K
ip4ep57xp bysvtdp7ev
10 Apr 18
Regulation FD Disclosure
12:00am
8-K
zcvby
9 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
1f0532 io6m
13 Mar 18
Regulation FD Disclosure
12:00am
8-K
9v7n4ni
8 Mar 18
PDL BioPharma Announces Fourth Quarter and Year End 2017 Financial Results
12:00am
8-K
id1jf65ub0
21 Feb 18
Regulation FD Disclosure
12:00am
8-K
0zcs4 kp0n
20 Feb 18
PDL BioPharma Terminates Interest in Pursuing Acquisition of Neos
12:00am
8-K
zbexezz7urzpnjg
21 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
4sj0xl0c0labmm2bc26
14 Nov 17
Regulation FD Disclosure
12:00am
8-K
r5n5e98r sjq6
8 Nov 17
PDL Urges Neos to Provide Update on Sale Process
12:00am
8-K
coioir43igzntx04 lti
2 Nov 17
PDL BioPharma Announces Third Quarter 2017 Financial Results
12:00am
8-K
mz0 b981zu0ivkdlqw64
30 Oct 17
PDL BioPharma Announces Settlement Agreement with Valeant
12:00am
8-K
307gtj0
30 Oct 17
PDL BioPharma Issues Statement in Response to Neos Therapeutics Rejection of PDL Acquisition Proposal
12:00am
8-K
ix4n9es byvprc9yin
26 Oct 17
PDL BioPharma Proposes to Acquire Neos Therapeutics for $10.25 per Share in Cash
12:00am
8-K
v20s2h9s
12 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
6tkjz1z 4f
25 Sep 17
Regulation FD Disclosure
12:00am
8-K
6jsmauii
21 Sep 17
Completion of Acquisition or Disposition of Assets
12:00am
8-K
m6wluhcefbl5m0lmqj
11 Sep 17
Regulation FD Disclosure
12:00am
8-K
3r1 mrpwt
11 Sep 17
PDL BioPharma Appoints Dominique Monnet as President
12:00am
8-K
05n0inh7 u2tlxgcml
3 Aug 17
PDL BioPharma Announces Second Quarter 2017 Financial Results
12:00am
8-K
6yzosmsvb 6hdeo
12 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am